{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T19:10:42Z","timestamp":1719947442289},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10620-023-08153-3","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T18:01:49Z","timestamp":1700071309000},"page":"7-9","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications"],"prefix":"10.1007","volume":"69","author":[{"given":"En Xian Sarah","family":"Low","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"8153_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2015","unstructured":"Imhann F, Bonder MJ, Vich Vila A et al. Proton pump inhibitors affect the gut microbiome. Gut. 2015;65:740\u2013748. https:\/\/doi.org\/10.1136\/gutjnl-2015-310376.","journal-title":"Gut."},{"issue":"2","key":"8153_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MEG.0000000000001499","volume":"32","author":"T Janka","year":"2020","unstructured":"Janka T, Tornai T, Borb\u00e9ly B et al. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. Eur J Gastroenterol Hepatol. 2020;32:257\u2013264. https:\/\/doi.org\/10.1097\/MEG.0000000000001499.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"8153_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clinimag.2021.04.034","volume":"77","author":"R Dai","year":"2021","unstructured":"Dai R, Sag AA, Martin JG et al. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: replication in an independent patient cohort. Clin Imaging. 2021;77:187\u2013192. https:\/\/doi.org\/10.1016\/j.clinimag.2021.04.034.","journal-title":"Clin Imaging."},{"issue":"33","key":"8153_CR4","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.3748\/wjg.v25.i33.4933","volume":"25","author":"MA De Roza","year":"2019","unstructured":"De Roza MA, Kai L, Kam JW et al. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol. 2019;25:4933\u20134944. https:\/\/doi.org\/10.3748\/wjg.v25.i33.4933.","journal-title":"World J Gastroenterol."},{"issue":"5","key":"8153_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","volume":"62","author":"R Terg","year":"2015","unstructured":"Terg R, Casciato P, Garbe C et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015;62:1056\u20131060. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.036.","journal-title":"J Hepatol."},{"key":"8153_CR6","doi-asserted-by":"publisher","unstructured":"Wong ZYY, Koh JH, Muthiah M, et al. Proton pump inhibitors increases longitudinal risk of mortality, decompensation and infection in cirrhosis: a meta analysis. Dig Dis Sci. (Epub ahead of print). https:\/\/doi.org\/10.1007\/s10620-023-08150-6.","DOI":"10.1007\/s10620-023-08150-6"},{"issue":"1","key":"8153_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2022.03.052","volume":"163","author":"N Mahmud","year":"2022","unstructured":"Mahmud N, Serper M, Taddei TH, Kaplan DE. The association between proton pump inhibitor exposure and key liver-related outcomes in patients with cirrhosis: A Veterans affairs cohort study. Gastroenterology. 2022;163:257\u2013269.e6. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.052.","journal-title":"Gastroenterology."},{"issue":"9","key":"8153_CR8","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/liv.13862","volume":"38","author":"TL Tergast","year":"2018","unstructured":"Tergast TL, Wranke A, Laser H et al. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis. Liver Int. 2018;38:1602\u20131613. https:\/\/doi.org\/10.1111\/liv.13862.","journal-title":"Liver Int."},{"issue":"7","key":"8153_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1365-2362.2011.02643.x","volume":"42","author":"LG van Vlerken","year":"2012","unstructured":"van Vlerken LG, Huisman EJ, van Hoek B et al. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. Eur J Clin Invest. 2012;42:760\u2013767. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02643.x.","journal-title":"Eur J Clin Invest."},{"key":"8153_CR10","doi-asserted-by":"publisher","first-page":"763370","DOI":"10.3389\/fmed.2021.763370","volume":"8","author":"S Sun","year":"2021","unstructured":"Sun S, Ye W, Zhao R et al. Proton pump inhibitor therapy does not affect prognosis of cirrhosis patients with acute decompensation and acute-on-chronic liver failure: A single-center prospective study. Front Med (Lausanne). 2021;8:763370. https:\/\/doi.org\/10.3389\/fmed.2021.763370.","journal-title":"Front Med (Lausanne)."},{"key":"8153_CR11","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.eclinm.2023.101924","volume":"58","author":"L China","year":"2023","unstructured":"China L, Tittanegro T, Crocombe D et al. Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: A post-hoc analysis of the ATTIRE trial. EClinicalMedicine. 2023;58:101924. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101924.","journal-title":"EClinicalMedicine."},{"issue":"4","key":"8153_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R De Franchis","year":"2022","unstructured":"De Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII\u2014Renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022.","journal-title":"J Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08153-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08153-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T10:34:12Z","timestamp":1705142052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08153-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8153"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08153-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}